REcurrent LArynx tumor or Treatment Effects?
- Conditions
- aryngeal and hypopharyngeal carcinoma
- Registration Number
- NL-OMON23713
- Lead Sponsor
- MC Utrecht
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
Recurrent laryngeal or hypopharyngeal carcinoma after radiotherapy with or without chemotherapy and scheduled for a salvage total laryngectomy. Over the age of 18. Given informed consent.
Exclusion Criteria
Contraindication for MRI at 3T and/or CT contrast administration. Insulin dependent diabetes mellitus.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Value of various imaging parameters at tumorous and non-tumorous tissue.
- Secondary Outcome Measures
Name Time Method Improvement of radiologists' ability to delineate tumor with the outcomes of this study.